Black Rock Inc. Onconova Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 248,878 shares of ONTX stock, worth $146,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares

248,878

Previous 248,878 -0.0%

Holding current value

$146,838

Previous $251,000 41.83%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.67 - $1.01 $2 - $3	-3 Reduced -0.0%	248,878 $251,000
Q4 2021 Feb 10, 2022	SELL	$2.49 - $3.73 $5,550 - $8,314	-2,229 Reduced 0.89%	248,881 $635,000
Q3 2021 Nov 09, 2021	SELL	$3.81 - $6.76 $1,093 - $1,940	-287 Reduced 0.11%	251,110 $961,000
Q2 2021 Aug 11, 2021	BUY	$6.28 - $16.2 $1.58 Million - $4.07 Million	251,397 New	251,397 $1.74 Million

Others Institutions Holding ONTX

# of Institutions

Shares Held

249K

Call Options Held

Put Options Held

View Full List

About Onconova Therapeutics, Inc.

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

More about ONTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account